0001567619-20-019011.txt : 20201110 0001567619-20-019011.hdr.sgml : 20201110 20201110102529 ACCESSION NUMBER: 0001567619-20-019011 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201110 DATE AS OF CHANGE: 20201110 EFFECTIVENESS DATE: 20201110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elucida Oncology, Inc. CENTRAL INDEX KEY: 0001704594 IRS NUMBER: 471358366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380142 FILM NUMBER: 201299960 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 805-691-9355 MAIL ADDRESS: STREET 1: 228 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0001704594 Elucida Oncology, Inc. 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 646-701-5391 DELAWARE Claymore Technologies Inc. None Corporation true Geno Germano 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Tim Boris 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Michael Smith 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Robert Essner 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Teresa Ressel 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Ulrich Wiesner 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Robert Ruffolo 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Eliel Bayever 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Kai Ma 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Gregory Adams 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Biotechnology No Revenues 06b false 2020-10-28 false true true false 12500 Maxim Group LLC 12078 None None 405 Lexington Avenue New York NY NEW YORK 10174 All States false 35000000 17693118 17306882 false 149 1769312 0 In addition, the Company issued the placement agent Warrants to purchase 2,328,035 shares of common stock of Elucida in connection with the offering. 0 false Elucida Oncology, Inc. /s/ Geno Germano Geno Germano CEO 2020-11-10